Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Optical treatment of nystagmus
ISRCTN ISRCTN80219391
ClinicalTrials.gov identifier
Public title Optical treatment of nystagmus
Scientific title A quantitative study comparing hard and soft contact lenses to spectacles on changes in nystagmus oscillations
Acronym N/A
Serial number at source Version 1
Study hypothesis Our hypothesis is that nystagmus can be improved with contact lens wearing. The specific research questions are:
1. Do contact lenses reduce nystagmus and improve vision compared to spectacle wearing?
2. Are hard contact lenses better than soft contact lenses for reducing nystagmus and improving vision in nystagmus?
Lay summary
Ethics approval Leicestershire, Northamptonshire and Rutland Research Ethics Committee 1 approved on the 6th July 2010 (ref: 10/H0406/40)
Study design Randomised single centre unmasked cross-over study
Countries of recruitment United Kingdom
Disease/condition/study domain Nystagmus
Participants - inclusion criteria Infantile nystagmus over the age of 16 years, either sex
Participants - exclusion criteria 1. Currently involved in surgical or pharmacological trials for the treatment of nystagmus
2. Previous corneal trauma or intolerence to contact lens wearing
Anticipated start date 01/09/2010
Anticipated end date 01/09/2012
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 28
Interventions Patients will take part in the trial for a total duration of 8 weeks. This will comprise of 2 weeks of spectacle wear followed by 2 weeks of hard or soft contact lens wear. The next 2 weeks the patients will be wearing the opposite type of contact lens to those prescribed previously and then finally 2 weeks of spectacle wear again. Details of each visit are below:

Visit 1: Optimal refraction determined and glasses prescribed and contact lenses fitted and ordered followed by EXAMINATION 1
Day 1 - 14: Spectacle wearing (minimum of 14 days)
Visit 2 (day 14): EXAMINATION 2 followed by contact lens type 1
Day 15 - 28: Contact lens type 1 wearing
Visit 3 (day 28): EXAMINATION 3 followed by contact lens type 2
Day 29 - 42: Contact lens type 2 wearing
Visit 4 (day 42): EXAMINATION 4 followed by spectacle wearing
Day 43 - 56: Spectacle wearing
Visit 5 (day 56): EXAMINATION 5
Primary outcome measure(s) Changes in nysatgmus intensity measured with eye movement recordings, measured at baseline, day 14, day 28, day 42 and day 56.
Secondary outcome measure(s) Measured at baseline, day 14, day 28, day 42 and day 56:
1. Changes in LogMAR (chart) visual acuity at 4M (with head free)
2. Changes in LogMAR (chart) visual acuity at 0.4M (with head free)
3. Change in gaze dependant visual acuity at 4M
4. Change in nystgamus intensity, NAFX function and reading speed will be evaluated from the eye movement recordings at different fixation points across the horizontal plane
5. Subjective changes in visual function evaluated with the VFQ25
Sources of funding University of Leicester (UK)
Trial website
Publications
Contact name Prof  Irene  Gottlob
  Address Ophthalmology Group
University of Leicester
Robert Kilpatrick Clinical Sciences Building (RKCSB)
  City/town Leicester
  Zip/Postcode LE2 7LX
  Country United Kingdom
  Tel +44 (0)116 258 6291
  Fax +44 (0)116 255 8810
  Email ig15@le.ac.uk
Sponsor University of Leicester (UK)
  Address Faculty of Medicine and Biological Sciences (MSB)
University Road
  City/town Leicester
  Zip/Postcode LE2 7LX
  Country United Kingdom
  Tel +44 (0)116 223 1262
  Fax +44 (0)116 252 3031
  Email gjh13@leicester.ac.uk
  Sponsor website: http://www.le.ac.uk/sm/le
Date applied 08/07/2010
Last edited 11/08/2010
Date ISRCTN assigned 11/08/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central